Atropine Use with Clozapine: Safety Considerations

Introduction to Anticholinergic Toxicity

Clozapine possesses significant anticholinergic properties, causing sedation, hypersalivation, tachycardia, and constipation in patients, according to the American Academy of Child and Adolescent Psychiatry 1, 2

Atropine remains the first-line treatment for acute symptomatic bradycardia at 0.5 mg IV every 3-5 minutes up to 3 mg total, as recommended by the American Heart Association 3, 4
The life-threatening nature of severe bradycardia outweighs anticholinergic interaction concerns in emergency situations, as stated by the American Heart Association 3
Monitor closely for anticholinergic toxicity symptoms including fever, confusion, hallucinations, and severe constipation, as advised by the American Heart Association 5

Clozapine commonly causes tachycardia and orthostatic hypotension in patients, according to the American Academy of Child and Adolescent Psychiatry 1, 2
Atropine increases heart rate through anticholinergic mechanisms, which may precipitate dangerous tachyarrhythmias, particularly in patients with underlying cardiac disease, as warned by the American Heart Association 3, 5

Use the minimum effective dose of atropine, starting with 0.5 mg IV for bradycardia, and monitor intensively for central anticholinergic syndrome, severe constipation, cardiac arrhythmias, and QT prolongation, as recommended by the American Heart Association 3, 4, 5
Consider alternatives to atropine, such as transcutaneous pacing, dopamine, or epinephrine infusions for bradycardia, and glycopyrrolate for hypersalivation, as suggested by the American Heart Association 3, 6

Do not use atropine doses <0.5 mg, as paradoxical bradycardia may occur, which is particularly dangerous in clozapine patients already at cardiovascular risk, as warned by the American Heart Association and the American Society of Anesthesiologists 3, 5, 8